Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests
CONCLUSIONS: Our concept and resulting algorithm are consistent, transparent, and easyto follow, and the method for derivation from consensus-based thresholds may also be applicableto other drug toxicity areas.PMID:38482670 | DOI:10.1080/14740338.2024.2327509
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Michael Merz Anna Fettiplace John Marcinak Hans L Tillmann Don C Rockey Gerd A Kullak-Ublick Source Type: research
More News: Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Liver | Toxicology | Urology & Nephrology